FindTrial
Sign In

Study of prescribing patterns of proton pump inhibitors in patients with acid reflux disorder

Drug utilization study of proton pump inhibitors in patients with acid reflux disorder in tertiary care hospital - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/099394
Enrollment
100
Registered
2025-12-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Indus International Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of all age groups and both sexes Patients with a primary or secondary diagnosis of acid reflux disorders Patients receiving at least one PPI during their hospital stay

Exclusion criteria

Exclusion criteria: Patients not diagnosed with acid reflux disorders Patients not receiving PPIs Patients with incomplete medical records

Design outcomes

Primary

MeasureTime frame
Identifying the PPI that is most commonly prescribed in hospital settings A qualitative and quantitative examination of PPI prescription trends. Calculation of the proportion of irrational versus sensible PPI prescriptions according to indication, dosage, and length of timeTimepoint: baseline, day 7, and 6 month—

Secondary

MeasureTime frame
The rate of prolonged therapy or improper prophylactic usage is estimated. The creation of evidence-based guidelines for the sensible prescription of PPIs, which can be shared with physicians to enhance practice habits.Timepoint: baseline, day 7, & 6 month—

Countries

India

Contacts

Public ContactAvantika Chandra

Indus International Hospital

msiih@indushospitals.com8872735888

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026